Massachusetts General Hospital Sleep Disorders Clinical Research Program

Massachusetts General Hospital Sleep Disorders Clinical Research Program We are part of the Psychiatry Department at Massachusetts General Hospital, and are dedicated to clinical and investigative efforts in sleep disorders.

Our team is made up of researchers who are affiliated with MGH and Harvard Medical School.

Our team at MGH wants to see whether an FDA-approved sleeping medication will improve sleep in people who have treated r...
06/22/2021

Our team at MGH wants to see whether an FDA-approved sleeping medication will improve sleep in people who have treated restless legs syndrome (RLS). Eligible participants need to be using a prescribed medication for diagnosed RLS, and must have persistent sleeping difficulties (even with use of the RLS medication).

No travel to Boston is necessary: all study meetings occur virtually. Participants are paid for each study visit.

Those who are interested in this research should visit the following website:

https://rally.partners.org/study/insomnia_treatedrls.

This 10-week study requires 5 virtual meetings and is investigating the use of an FDA-approved sleeping medication to improve sleep in people who have treated restless legs syndrome.

Our team of researchers at Harvard and Massachusetts General Hospital wants to see if an FDA-approved sleeping medicatio...
03/25/2021

Our team of researchers at Harvard and Massachusetts General Hospital wants to see if an FDA-approved sleeping medication will improve sleep and blood sugar levels in people with type 2 diabetes.

All visits can occur virtually; no travel to MGH is required. Participants are paid for each study visit.

To learn more about this study, please visit the following website: https://rally.partners.org/study/insomnia_type2diabetes.

This 12-week study requires 4 visits (all of which can occur virtually) and is investigating the use of an FDA-approved sleeping medication to improve sleep and other aspects of health in people who have type 2 diabetes.

Our team at MGH wants to see if an FDA-approved sleeping medication will improve sleep and blood sugar levels in people ...
11/25/2020

Our team at MGH wants to see if an FDA-approved sleeping medication will improve sleep and blood sugar levels in people with type 2 diabetes.

All visits can occur virtually; no travel to MGH is required. Participants are paid for each study visit.

To learn more about this research study, please visit the following website: https://rally.partners.org/study/insomnia_type2diabetes.

This 12-week study requires 4 visits and is investigating the use of an FDA-approved sleeping medication to improve sleep in people who have type 2 diabetes. We are investigating whether improved sleep might improve type 2 diabetes.

We want to see whether an FDA-approved sleeping medication will improve sleep and blood sugar levels in people with type...
07/29/2020

We want to see whether an FDA-approved sleeping medication will improve sleep and blood sugar levels in people with type 2 diabetes. No travel to MGH is necessary: all study visits can occur virtually. Three blood draws are required, which can be performed at a local site.

Those who are interested in this research should email sleepdiabetes@mgh.harvard.edu or visit the following website:

https://rally.partners.org/study/insomnia_type2diabetes.

This 12-week study requires 4 visits and is investigating the use of an FDA-approved sleeping medication to improve sleep in people who have type 2 diabetes. We are investigating whether improved sleep might improve type 2 diabetes.

We want to see whether an FDA-approved sleeping medication will improve sleep and blood sugar levels in people with type...
04/13/2020

We want to see whether an FDA-approved sleeping medication will improve sleep and blood sugar levels in people with type 2 diabetes. Those who are interested in this research should email sleepdiabetes@mgh.harvard.edu.

This 12-week study requires 4 visits and is investigating the use of an FDA-approved sleeping medication to improve sleep in people who have type 2 diabetes. We are investigating whether improved sleep might improve type 2 diabetes.

We are dedicated to clinical research on sleep disorders, including insomnia in type 2 diabetics, restless legs syndrome...
03/11/2020

We are dedicated to clinical research on sleep disorders, including insomnia in type 2 diabetics, restless legs syndrome, and sleep-related eating disorder. Visit our page to learn more about our studies.

https://www.massgeneral.org/psychiatry/research/sleep-disorders-clinical-research-program

The Sleep Disorders Clinical Research Program at Mass General is dedicated to clinical and investigative efforts in sleep disorders, including restless legs syndrome, insomnia and sleep-related eating disorder.

Address

One Bowdoin Square
Boston, MA
02114

Website

Alerts

Be the first to know and let us send you an email when Massachusetts General Hospital Sleep Disorders Clinical Research Program posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Massachusetts General Hospital Sleep Disorders Clinical Research Program:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category